Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer gene therapy

Showing results (11-20 of 3,040) with videos related to

Pageof 304
Sort By:
Cancer Gene Therapy|December 1, 2022
Novel treatment paradigms for metastatic uveal melanomaSapna P Patel, Steven C Katz
Cancer Gene Therapy|December 2, 2022
GAS5 attenuates the malignant progression of glioma stem-like cells by promoting E-cadherinHaiyang Wang, Ding Wang, Yongfeng Shen, et al.
Cancer Gene Therapy|June 5, 2024
Retraction Note: miR-182 regulates trastuzumab resistance by targeting MET in breast cancer cellsDan Yue, Xiaosong Qin
Cancer Gene Therapy|May 28, 2019
CMV enhancer may not be suitable for tissue-specific enhancement of promoters in cancer gene therapyZhenyu Jia, Jing Jia, Shuzhi Zhang, et al.
Cancer Gene Therapy|July 25, 2022
The combination of ruxolitinib and Bcl-2/Mcl-1 inhibitors has a synergistic effect on leukemic cells carrying a SPAG9::JAK2 fusionAzusa Mayumi, Toshihiro Tomii, Takuyo Kanayama, et al.
Cancer Gene Therapy|April 20, 2022
3JC48-3 (methyl 4'-methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1'-biphenyl]-3-carboxylate): a novel MYC/MAX dimerization inhibitor reduces prostate cancer growthSanjeev Shukla, Steven Fletcher, Jay Chauhan, et al.
Cancer Gene Therapy|April 21, 2022
Challenges and progress toward tumor-targeted therapy by systemic delivery of polymer-complexed oncolytic adenovirusesThavasyappan Thambi, JinWoo Hong, A-Rum Yoon, et al.
Cancer Gene Therapy|October 19, 2010
Retraction. Bleomycin/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogs
Cancer Gene Therapy|October 2, 2010
Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-γ-dependent response against B16F10-Nex2 melanomaL H L Marchi, T Paschoalin, L R Travassos, et al.
Cancer Gene Therapy|November 6, 2010
Enhanced antitumor activity by combining an adenovirus harboring ING4 with cisplatin for hepatocarcinoma cellsY Xie, W Sheng, J Miao, et al.
Pageof 304

Showing results (11-20 of 3,040) with videos related to

Sort By:
Pageof 304
Cancer Gene Therapy|December 1, 2022
Novel treatment paradigms for metastatic uveal melanomaSapna P Patel, Steven C Katz
Cancer Gene Therapy|December 2, 2022
GAS5 attenuates the malignant progression of glioma stem-like cells by promoting E-cadherinHaiyang Wang, Ding Wang, Yongfeng Shen, et al.
Cancer Gene Therapy|June 5, 2024
Retraction Note: miR-182 regulates trastuzumab resistance by targeting MET in breast cancer cellsDan Yue, Xiaosong Qin
Cancer Gene Therapy|May 28, 2019
CMV enhancer may not be suitable for tissue-specific enhancement of promoters in cancer gene therapyZhenyu Jia, Jing Jia, Shuzhi Zhang, et al.
Cancer Gene Therapy|July 25, 2022
The combination of ruxolitinib and Bcl-2/Mcl-1 inhibitors has a synergistic effect on leukemic cells carrying a SPAG9::JAK2 fusionAzusa Mayumi, Toshihiro Tomii, Takuyo Kanayama, et al.
Cancer Gene Therapy|April 20, 2022
3JC48-3 (methyl 4'-methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1'-biphenyl]-3-carboxylate): a novel MYC/MAX dimerization inhibitor reduces prostate cancer growthSanjeev Shukla, Steven Fletcher, Jay Chauhan, et al.
Cancer Gene Therapy|April 21, 2022
Challenges and progress toward tumor-targeted therapy by systemic delivery of polymer-complexed oncolytic adenovirusesThavasyappan Thambi, JinWoo Hong, A-Rum Yoon, et al.
Cancer Gene Therapy|October 19, 2010
Retraction. Bleomycin/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogs
Cancer Gene Therapy|October 2, 2010
Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-γ-dependent response against B16F10-Nex2 melanomaL H L Marchi, T Paschoalin, L R Travassos, et al.
Cancer Gene Therapy|November 6, 2010
Enhanced antitumor activity by combining an adenovirus harboring ING4 with cisplatin for hepatocarcinoma cellsY Xie, W Sheng, J Miao, et al.
Pageof 304